Explore
Trendline
Diageo's $1 Billion Cost-Cutting Plan Boosts Shares Amid Restructuring
Diageo's $1 Billion Cost-Cutting Plan Boosts Shares Amid Restructuring
Read More
Trendline
Pfizer Reports Strong Q2 Results, Adjusts Revenue Outlook Amid Non-Covid Product Growth
Pfizer Reports Strong Q2 Results, Adjusts Revenue Outlook Amid Non-Covid Product Growth
Read More
Trendline
Pfizer Adjusts 2026 Revenue Forecast Amid Decline in Covid-19 Product Sales
Pfizer Adjusts 2026 Revenue Forecast Amid Decline in Covid-19 Product Sales
Read More
Trendline
Pfizer Raises 2026 Revenue Guidance Despite Decline in Covid-19 Sales
Pfizer Raises 2026 Revenue Guidance Despite Decline in Covid-19 Sales
Read More
Trendline
Pfizer Increases Revenue Guidance Amid Decline in COVID-19 Drug Sales
Pfizer Increases Revenue Guidance Amid Decline in COVID-19 Drug Sales
Read More
Trendline
Pfizer's Quarterly Earnings Surpass Expectations Amid Decline in COVID-19 Product Sales
Pfizer's Quarterly Earnings Surpass Expectations Amid Decline in COVID-19 Product Sales
Read More
Trendline
Pfizer Adjusts 2026 Revenue Guidance Amid Decline in Covid-19 Sales
Pfizer Adjusts 2026 Revenue Guidance Amid Decline in Covid-19 Sales
Read More
Trendline
Pfizer Announces $2.5 Billion in Additional Cost Savings Amid Revenue Growth
Pfizer Announces $2.5 Billion in Additional Cost Savings Amid Revenue Growth
Read More
Trendline
Pfizer's Quarterly Results Exceed Expectations Amid Drug Sales Growth
Pfizer's Quarterly Results Exceed Expectations Amid Drug Sales Growth
Read More
Trendline
Pfizer Reports Q2 2026 Earnings Beat and Raises Revenue Guidance
Pfizer Reports Q2 2026 Earnings Beat and Raises Revenue Guidance
Read More
Trendline
Eli Lilly Increases Revenue Forecast Amid Strong Sales of New Medications
Eli Lilly Increases Revenue Forecast Amid Strong Sales of New Medications
Read More
Trendline
Merck Adjusts Revenue and Profit Outlook Amid Acquisition Charges
Merck Adjusts Revenue and Profit Outlook Amid Acquisition Charges
Read More
